Literature DB >> 30867245

The Other Glucose Transporter, SGLT1 - Also a Potential Trouble Maker in Diabetes?

Mattias Carlström1.   

Abstract

Entities:  

Keywords:  diabetes; glomerular hyperfiltration; nitric oxide; renal function

Mesh：

Substances：

Year:  2019        PMID： 30867245      PMCID： PMC6442345          DOI： 10.1681/ASN.2019020171

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

Review 3.  Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

Review 4.  Development of SGLT1 and SGLT2 inhibitors.

Authors:  Timo Rieg; Volker Vallon
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

5.  Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.

Authors:  V Vallon; K Richter; R C Blantz; S Thomson; H Osswald
Journal:  J Am Soc Nephrol       Date:  1999-12       Impact factor: 10.121

6.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Authors:  Radica Z Alicic; Michele T Rooney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

7.  Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia.

Authors:  Jie Zhang; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Jacentha Buggs; Hermann Koepsell; Volker Vallon; Ruisheng Liu
Journal:  J Am Soc Nephrol       Date:  2019-03-13       Impact factor: 10.121

8.  SGLT2 Inhibitors and the Diabetic Kidney.

Authors:  Paola Fioretto; Alberto Zambon; Marco Rossato; Luca Busetto; Roberto Vettor
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

9.  Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension.

Authors:  Yan Lu; Jin Wei; David E Stec; Richard J Roman; Ying Ge; Liang Cheng; Eddie Y Liu; Jie Zhang; Pernille B Laerkegaard Hansen; Fan Fan; Luis A Juncos; Lei Wang; Jennifer Pollock; Paul L Huang; Yiling Fu; Shaohui Wang; Ruisheng Liu
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

Review 10.  SGLT1 inhibition: Pros and cons.

Authors:  Vasilis Tsimihodimos; Sebastien Filippas-Ntekouan; Moses Elisaf
Journal:  Eur J Pharmacol       Date:  2018-09-18       Impact factor: 4.432
  10 in total
  2 in total

1.  Knockout of Macula Densa Neuronal Nitric Oxide Synthase Increases Blood Pressure in db/db Mice.

Authors:  Jie Zhang; Ximing Wang; Yu Cui; Shan Jiang; Jin Wei; Jenna Chan; Anish Thalakola; Thanh Le; Lan Xu; Liang Zhao; Lei Wang; Kun Jiang; Feng Cheng; Trushar Patel; Jacentha Buggs; Volker Vallon; Ruisheng Liu
Journal:  Hypertension       Date:  2021-10-18       Impact factor: 10.190

2.  Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration.

Authors:  Jie Zhang; Jing Cai; Yu Cui; Shan Jiang; Jin Wei; Young Chul Kim; Jenna Chan; Anish Thalakola; Thanh Le; Lan Xu; Lei Wang; Kun Jiang; Ximing Wang; Haibo Wang; Feng Cheng; Jacentha Buggs; Hermann Koepsell; Volker Vallon; Ruisheng Liu
Journal:  Kidney Int       Date:  2021-11-26       Impact factor: 18.998
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.